Drug intelligence / Profile preview

Diling Weitong Granules

Development stage: Unknown
Lead developer: Jiangsu Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Diling Weitong Granules is a traditional Chinese medicine (TCM) herbal formulation developed and marketed by Jiangsu Pharmaceutical Co., Ltd., a company associated with the Yangtze River Pharmaceutical Group. It is specifically indicated for the treatment of epigastric pain attributed to qi stagnation according to TCM diagnostic principles. As a multi-herb granule formulation, it is designed to work through the synergistic effects of its constituent herbal components to provide symptom relief for stomach pain and discomfort. The product is an approved pharmaceutical in China and is administered orally as granules.

Brand names: Diling Weitong Granules
Other names: Diling Weitong

Beyond the preview

Go deeper on Diling Weitong Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diling Weitong Granules.

Explore the full profile